GSK's Fluticasone Furoate Nasal Spray Against Allergic Rhinitis
Filed in archive Allergy Medications , Allergy: Research and Development , Hay Fever on March 1, 2007
GlaxoSmithKline's fluticasone furoate nasal spray (FFNS) is currently under US FDA review.
Clinical data from two separate Phase III studies of FFNS, recently presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), showed that FFNS was effective and well-tolerated in treating a range of nasal allergy symptoms: congestion, sneezing, itchy and runny nose.
Currently under USFDA review for treatment of the symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR), fluticasone furoate nasal spray (FFNS) is an enhanced affinity intranasal corticosteroid (INS) that blocks the action of inflammatory mediators early in and throughout the allergy process.
Find more details from the press release.
Tags: nasal spray intranasal corticosteroid allergies allergic+rhinitis nasal+spray furoate+nasal
Vote for GSK's Fluticasone Furoate Nasal Spray Against Allergic Rhinitis:
|
Rating: 7.60 out of 5 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Allergy Basics
Allergy Blogs
Allergy Medications
Allergy Support Groups
Allergy to Drugs
Allergy: Diagnostics and Treatment
Allergy: Research and Development
Asthma
Best of
Did you know
Dust Mite Allergies
Food Allergies
Gadgets and Tools Against Allergies
Hay Fever
Information About
Insect Allergies
Latex/Rubber Allergies
Living with Allergies
Metal Allergies
Misc